Rosiglitazone (Avandia/Avandamet) and cardiovascular risk

Hdl Handle:
http://hdl.handle.net/10147/109647
Title:
Rosiglitazone (Avandia/Avandamet) and cardiovascular risk
Authors:
Irish Medicines Board (IMB)
Publisher:
Irish Medicines Board (IMB)
Issue Date:
28-Jul-2010
URI:
http://hdl.handle.net/10147/109647
Item Type:
Report
Language:
en
Keywords:
DRUG; REGULATION; MEDICINES

Full metadata record

DC FieldValue Language
dc.contributor.authorIrish Medicines Board (IMB)en
dc.date.accessioned2010-08-16T14:22:39Z-
dc.date.available2010-08-16T14:22:39Z-
dc.date.issued2010-07-28-
dc.identifier.urihttp://hdl.handle.net/10147/109647-
dc.language.isoenen
dc.publisherIrish Medicines Board (IMB)en
dc.subjectDRUGen
dc.subjectREGULATIONen
dc.subjectMEDICINESen
dc.titleRosiglitazone (Avandia/Avandamet) and cardiovascular risken
dc.typeReporten
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.